|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2007-9-25
|
|
pubmed:abstractText |
The use of androgen deprivation therapy (ADT) in the treatment of men with prostate cancer has risen sharply. Although cardiovascular disease is the most common reason for death among men with prostate cancer who do not die of the disease itself, data regarding the effect of ADT on cardiovascular morbidity and mortality in men with prostate cancer are limited. In the current study, the authors attempted to measure the risk for subsequent cardiovascular morbidity in men with prostate cancer who received ADT.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
110
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1493-500
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17657815-Aged,
pubmed-meshheading:17657815-Aged, 80 and over,
pubmed-meshheading:17657815-Androgen Antagonists,
pubmed-meshheading:17657815-Antineoplastic Agents, Hormonal,
pubmed-meshheading:17657815-Cardiovascular Diseases,
pubmed-meshheading:17657815-Cohort Studies,
pubmed-meshheading:17657815-Educational Status,
pubmed-meshheading:17657815-Hispanic Americans,
pubmed-meshheading:17657815-Humans,
pubmed-meshheading:17657815-Kaplan-Meier Estimate,
pubmed-meshheading:17657815-Male,
pubmed-meshheading:17657815-Medicare,
pubmed-meshheading:17657815-Multivariate Analysis,
pubmed-meshheading:17657815-Prostatic Neoplasms,
pubmed-meshheading:17657815-Retrospective Studies,
pubmed-meshheading:17657815-Risk Assessment,
pubmed-meshheading:17657815-Risk Factors,
pubmed-meshheading:17657815-SEER Program,
pubmed-meshheading:17657815-Socioeconomic Factors,
pubmed-meshheading:17657815-United States
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer.
|
|
pubmed:affiliation |
Department of Urology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California 90095, USA. csaigal@mednet.ucla.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|
